许云龙

许云龙, listed as senior executive, appears in our data through filings on 康泰医学 shares, published by SSE / SZSE (CSRC). We count 4 filings; the first trade dates from 27 September 2021 and the latest from 28 July 2023.

Sales make up the whole of the open-market record (4 sales, €4.5M). In 2023 alone, the filings show no purchases and 1 sale.

On 28 July 2023 came the latest disclosure, an open-market sale for €1.1M in 康泰医学. Most trades are made public on the day they happen. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.